| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/11/2009 | WO2009070875A1 Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies |
| 06/11/2009 | WO2008157380A3 Chemically modified cyclic peptides containing cell adhesion recognition (car) sequences and uses therefor |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | US20090149632 Antibacterial peptide |
| 06/11/2009 | US20090149393 Novel Proteins Within The Type E Botulinum Neurotoxin Complex |
| 06/11/2009 | US20090149391 Novel antimicrobial bolisin peptides |
| 06/11/2009 | US20090149390 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 06/11/2009 | US20090149380 Vasostatin as marrow protectant |
| 06/11/2009 | US20090148922 Pancreatic Cancer Genes |
| 06/11/2009 | US20090148921 Compositions and methods for enhancing apoptosis |
| 06/11/2009 | US20090148468 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 06/11/2009 | US20090148456 Canine rankl and methods for preparing and using the same |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | CA2853475A1 Genes that increase plant oil and method for using the same |
| 06/11/2009 | CA2708322A1 Genes that increase plant oil and method for using the same |
| 06/11/2009 | CA2708321A1 Genes that increase plant oil and method for using the same |
| 06/11/2009 | CA2707870A1 Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies |
| 06/11/2009 | CA2707589A1 Allele- and isotype-specific intervention by means of peptides on mhc class ii molecules associated with autoimmune diseases |
| 06/11/2009 | CA2706907A1 Cancer vaccine composition |
| 06/10/2009 | EP2067790A2 Agonist antibody against protein tyrosine kinase SAL-S1 |
| 06/10/2009 | EP2067785A1 Human CD154-binding synthetic peptide and uses thereof |
| 06/10/2009 | EP2066689A1 Hyd1 peptides as anti-cancer agents |
| 06/10/2009 | CN101454340A Cancer imaging and treatment |
| 06/10/2009 | CN101454339A Peptides for use in diagnosing the presence of ruptured atherosclerotic lesions in an individual |
| 06/10/2009 | CN100497384C Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 06/10/2009 | CN100497373C Novel melanocortin receptor templates, peptides, and use thereof |
| 06/09/2009 | US7544781 Polypeptide and process for producing the same |
| 06/09/2009 | US7544773 Antimicrobials against pathogenic bacteria and method for screening them |
| 06/09/2009 | US7544768 Peptides for inducing apoptosis in tumor cells |
| 06/09/2009 | US7544666 NAP derivatives |
| 06/09/2009 | US7544664 Sequences facilitating penetration of a substance of interest |
| 06/09/2009 | US7544661 Micellular reaction product of a peptide and a growth factor recognition ligand for growth factors selected from bone morphogenic protein-2, TGF- beta 1, VEGF, FGF-2, nerve growth factor-3 and laminin-5 and made from mesenchymal stem cells; improved bioavailability |
| 06/09/2009 | US7544653 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 06/04/2009 | WO2009069302A1 Stat3 epitope peptides |
| 06/04/2009 | WO2009022339A9 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 06/04/2009 | WO2009022154A3 Peptide with multiple epitopes |
| 06/04/2009 | US20090143567 Multiblock copolymers having improved mechanical properties |
| 06/04/2009 | US20090143566 Growth Factor Analogs |
| 06/04/2009 | US20090143565 Methods for the Synthesis of Two or More Dicarba Bridges in Organic Compounds |
| 06/04/2009 | US20090143529 Peptide purification by means of hard metal ion affinity chromatography |
| 06/04/2009 | US20090143312 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/04/2009 | US20090143309 converting an agonist of protein kinase C to an antagonist of protein kinase C; amino acid sequences; crosslinked via an N-terminal Cys-Cys bond to a peptide to facilitate transport cellular uptake |
| 06/04/2009 | US20090143308 Yeast membrane protein expression system and its application in drug screening |
| 06/04/2009 | US20090143303 Anti-invasive and anti-angiogenic compositions |
| 06/04/2009 | US20090143299 Novel antimicrobial peptides and use thereof |
| 06/04/2009 | US20090143293 Peptide inhibitors of protein kinase C gamma for pain management |
| 06/04/2009 | US20090143291 Tumor antigen based on products of the tumor suppressor gene wt1 |
| 06/04/2009 | US20090142794 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/04/2009 | US20090142784 Methods |
| 06/04/2009 | US20090142364 Method for finding novel peptide immunostimulatory adjuvants, compositions and methods of use |
| 06/04/2009 | US20090142363 Cytotoxic t-cell epitope peptide and use thereof |
| 06/04/2009 | DE102007059924A1 Allel- und Isotyp-spezifische Intervention an mit Autoimmunerkrankungen assoziierten MHC-Klasse-II-Molekülen durch Peptide Allelic and isotype-specific intervention in associated with autoimmune diseases MHC class II molecules by peptides |
| 06/04/2009 | CA2706835A1 Stat3 epitope peptides |
| 06/03/2009 | EP2064228A2 Synthetic peptide amides |
| 06/03/2009 | EP2063918A2 Compounds and methods for 18f labeled agents |
| 06/03/2009 | EP1131426B1 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 06/03/2009 | CN101445551A BiP protein antigen epitope peptide, filtration method and application thereof |
| 06/03/2009 | CN100494218C Recombinant thymus pentapeptide structural analogs, its production and use |
| 06/03/2009 | CA2613075A1 Synthetic antigen mimetics immuno-reactive with rheumatoid arthritis auto-antibodies |
| 06/02/2009 | US7541429 Comparative ligand mapping from MHC positive cells |
| 06/02/2009 | US7541339 Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 06/02/2009 | US7541335 Nogo-receptors and methods of use |
| 06/02/2009 | US7541143 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples |
| 06/02/2009 | US7541018 Treatment process using somatostatin analogues |
| 06/02/2009 | CA2274495C Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 05/28/2009 | WO2009067520A2 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 05/28/2009 | WO2009067177A2 Bone morphogenic protein binding peptide |
| 05/28/2009 | WO2009066175A1 Peptide analogues and conjugates thereof |
| 05/28/2009 | WO2009065949A2 Peptide production and purification process |
| 05/28/2009 | WO2009026218A3 Identification and use of peptide inhibitors of protein synthesis |
| 05/28/2009 | US20090137489 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137488 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137485 Antigens Targeted by Pathogenic T Cells in Type 1 Diabetes and Uses Thereof |
| 05/28/2009 | US20090137484 Neuronal Network-Interacting Peptide |
| 05/28/2009 | US20090137483 Antagonists of the bradykinin B1 receptor |
| 05/28/2009 | US20090137482 Biologically active peptide and agent containing the same |
| 05/28/2009 | US20090137481 Antimicrobial polypeptides |
| 05/28/2009 | US20090137464 Therapeutic fibrin-derived peptides and uses thereof |
| 05/28/2009 | US20090137462 Pharmaceutical composition comprising cyclic somatostatin analogues |
| 05/28/2009 | US20090137460 Cross-linked glycopeptide-cephalosporin antibiotics |
| 05/28/2009 | US20090137452 Antagonists of the bradykinin B1 receptor |
| 05/28/2009 | US20090137419 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/28/2009 | US20090137051 Monoclonal Antibodies Directed Against The Microtubule-Associated Protein Tau |
| 05/28/2009 | US20090137050 Artificial protein, method for absolute quantification of proteins and uses thereof |
| 05/28/2009 | US20090136985 Vascular Aging-Predicting Factor and Utilization of the Same |
| 05/28/2009 | US20090136983 Target sequences for synthetic molecules |
| 05/28/2009 | US20090136548 Multiple antigenic peptides immunogenic against streptococcus pneumonia |
| 05/28/2009 | US20090136528 Novel immunogenic epitope for immunotherapy |
| 05/28/2009 | US20090136527 Synthetic peptide comprising the amino acid sequence GPRLGYSWHX in which each of the amino acids are in the D-amino acid configuration and X is any amino acid; optionally conjugated to the natural gonadotropin-releasing hormone peptide; vaccines for use incontrolling fertility or heat in an animal |
| 05/28/2009 | US20090136522 Multivalent Immunogen |
| 05/28/2009 | US20090136511 an oligopeptide capable of binding cellular IL-15R alpha or its soluble fraction and inhibiting IL-15-dependent T cell proliferation activity, used for treating rheumatoid arthritis and psoriasis in a mammal; immunogens |
| 05/28/2009 | US20090136503 Trail receptor-binding agents and uses of the same |
| 05/28/2009 | US20090136462 Peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen, Prostate acid phosphatase and Prostate specific membrane antigen, BA-46, Mucin, and Teratocarcinoma-derived growth factor; bladder, prostate and breast cancers; antimetastasis agents |
| 05/28/2009 | US20090136418 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 05/28/2009 | CA2707007A1 Peptide production and purification process |
| 05/28/2009 | CA2706882A1 Bone morphogenic protein binding peptide |
| 05/28/2009 | CA2706201A1 Peptides with capacity to bind to scurfin and applications |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062909A1 Peptide production and purification process |
| 05/27/2009 | EP2062590A1 Peptide derived from Hepatitis C virus |